Search Results for "PPARG" - 272 interactions found in 104 entries.

Entry-ID
Interactor1 (Subject) Interaction type Interactor2 (Object) additional information
PubMed-ID
Diseases
71
237 PPARG decreases_expression of NOS2 if PPARG is overexpressed in cytokine treated cells
238 PPARG decreases_expression of PTGS2 if PPARG is overexpressed in cytokine treated cells
247 PPARG increases_quantity of NFKBIA in cytosol; if PPARG is overexpressed in cytokine treated cells
17521952 Diabetes mellitus, type I
386
12688 Mitochondrial GPAT NOT affects_expression of PPARG in liver; if mitochondrial GPAT is overexpressed in liver
16507761 Diabetes mellitus, type II
Insulin resistance
Fatty liver disease, nonalcoholic
401
1751 GPAM NOT affects_quantity of PPARG
11546763 Diabetes mellitus, type II
Insulin resistance
732
4117 dietary fat affects_activity of PPARG in liver
16614395 Diabetes mellitus, type II
Insulin resistance
736
4221 LPIN1 increases_expression of PPARG
4231 LPIN1A increases_expression of PPARG
18023282 Diabetes mellitus, type II
Obesity
Lipodystrophy
Insulin resistance
Fatty liver disease, nonalcoholic
Majeed syndrome
824
4806 PPARGC1 affects_activity of PPARG
5002 PPARG increases_activity of lipid biosynthetic process in white adipose tissue
5004 PPARG increases_activity of lipid storage in white adipose tissue
5005 PPARG increases_activity of white fat cell differentiation in white adipose tissue
5010 canonical Wnt signaling pathway decreases_activity of PPARG
5015 NR1D1 increases_activity of PPARG
5024 PPARD affects_expression of PPARG
5076 SIRT1 interacts (colocalizes) with PPARG in adipose tissue, in mature adipocytes
5078 SIRT1 decreases_activity of PPARG in adipose tissue, in mature adipocytes
5082 LPIN1 interacts (colocalizes) with PPARG in white adipose tissue
19770177 Diabetes mellitus, type II
Obesity
Insulin resistance
889
5287 PPARGC1B affects_expression of PPARG if PPARGC1B expression is knocked down
19254570 Diabetes mellitus, type II
Insulin resistance
906
5438 SIRT1 affects_expression of PPARG in epididymal white adipose tissue; both splice variants PPAR-gamma1 and PPAR-gamma2, if SIRT1 is knocked down in liver and adipose tissue of diabetic rats
19549853 Diabetes mellitus, type II
Insulin resistance
1,092
7098 TNF decreases_expression of PPARG in adipose tissue
7105 PPARG affects_activity of glucose homeostasis
7312 PPARG affects_activity of fat cell differentiation
7316 Thiazolidinedione affects_activity of PPARG
7317 PPARG decreases_activity of inflammatory response in macrophages
18053812 Diabetes mellitus, type II
Obesity
Insulin resistance
1,203
8059 CCR2 affects_expression of PPARG in obese mice
8060 CCR2 NOT affects_expression of PPARG in lean mice
16341265 Diabetes mellitus, type II
Obesity
Insulin resistance
1,232
8382 C3AR1 NOT affects_expression of PPARG in epididymal white adipose tissue, in subcutaneous adipose tissue
19581423 Diabetes mellitus, type II
Insulin resistance
Fatty liver disease, nonalcoholic
1,292
8784 PPARG affects_activity of Insulin resistance in liver, in skeletal muscle; after myeloid-specific PPARG deletion
8785 PPARG affects_activity of insulin receptor signaling pathway in liver, in skeletal muscle; after myeloid-specific PPARG deletion
8786 PPARG affects_phosphorylation of IRS1 in liver, in skeletal muscle; after myeloid-specific PPARG deletion, at Tyr residues of IRS1
8787 PPARG affects_phosphorylation of AKT1 in liver, in skeletal muscle; after myeloid-specific PPARG deletion, at Ser residues of AKT1
8788 PPARG affects_activity of CHUK in liver, in skeletal muscle; after myeloid-specific PPARG deletion
8789 PPARG affects_activity of IKBKB in liver, in skeletal muscle; after myeloid-specific PPARG deletion
8790 PPARG affects_phosphorylation of CHUK in liver, in skeletal muscle; after myeloid-specific PPARG deletion
8791 PPARG affects_phosphorylation of IKBKB in liver, in skeletal muscle; after myeloid-specific PPARG deletion
8792 PPARG affects_activity of MAPK8 in liver, in skeletal muscle; after myeloid-specific PPARG deletion
8793 PPARG affects_phosphorylation of MAPK8 in liver, in skeletal muscle; after myeloid-specific PPARG deletion
8794 PPARG affects_quantity of Diacylglycerol in liver, in skeletal muscle; after myeloid-specific PPARG deletion
8795 PPARG affects_quantity of Triacylglycerol in liver, in skeletal muscle; after myeloid-specific PPARG deletion
8796 PPARG affects_quantity of Long-chain acyl-CoA in liver, in skeletal muscle; after myeloid-specific PPARG deletion
8797 PPARG affects_expression of CCL2 in adipose tissue; after myeloid-specific PPARG deletion
8798 PPARG affects_expression of VCAM1 in adipose tissue; after myeloid-specific PPARG deletion
8799 PPARG affects_expression of IL1B in adipose tissue; after myeloid-specific PPARG deletion
8800 PPARG affects_expression of VCAM1 in skeletal muscle; after myeloid-specific PPARG deletion
8801 PPARG affects_expression of IL1B in liver; after myeloid-specific PPARG deletion
8802 PPARG affects_expression of HMGCL in macrophage; after myeloid-specific PPARG deletion
8803 PPARG affects_expression of ABCG1 in macrophage; after myeloid-specific PPARG deletion
8804 PPARG affects_expression of ALDH3A1 in macrophage; after myeloid-specific PPARG deletion
8805 PPARG affects_expression of GCDH in macrophage; after myeloid-specific PPARG deletion
8806 PPARG affects_expression of ECH1 in macrophage; after myeloid-specific PPARG deletion
8807 PPARG affects_expression of UCP2 in macrophage; after myeloid-specific PPARG deletion
8808 PPARG affects_expression of CXCL1 in macrophage; after myeloid-specific PPARG deletion
8809 PPARG affects_expression of CXCL14 in macrophage; after myeloid-specific PPARG deletion
8810 PPARG affects_expression of CCL24 in macrophage; after myeloid-specific PPARG deletion
8811 PPARG affects_expression of CCR1 in macrophage; after myeloid-specific PPARG deletion
8812 PPARG affects_expression of RETNLA in macrophage; after myeloid-specific PPARG deletion
8813 PPARG affects_activity of Insulin resistance
8814 PPARG affects_activity of Thiazolidinedione after myeloid-specific PPARG deletion, after high-fat diet-induced insulin resistance
17525798 Diabetes mellitus, type II
Insulin resistance
1,405
9763 PPARG increases_expression of GPX3 in adipose tissue
18562625 Diabetes mellitus, type II
Obesity
Insulin resistance
1,445
10164 IL1B NOT affects_expression of PPARG
17038556 Diabetes mellitus, type II
Insulin resistance
1,455
10270 aging decreases_expression of PPARG in epididymal adipose tissue
17878382 Diabetes mellitus, type II
Insulin resistance
1,519
10778 Polyunsaturated fatty acid, omega-3 increases_expression of PPARG in adipose tissue
10781 Polyunsaturated fatty acid, omega-3 increases_expression of PPARG in liver
19211925 Diabetes mellitus, type II
Obesity
Insulin resistance
Fatty liver disease, nonalcoholic
1,559
11194 ADIPOQ affects_activity of PPARG in white adipose tissue
11195 ADIPOQ affects_expression of PPARG in adipose tissue
17717599 Diabetes mellitus, type II
Obesity
Insulin resistance
Fatty liver disease, nonalcoholic
1,567
11209 PPARG increases_quantity of HMW adiponectin complex in adipose tissue
11213 PPARG increases_activity of translation
19088251 Diabetes mellitus, type II
Insulin resistance
1,584
11404 Docosahexaenoic acid increases_expression of PPARG in kidney
11407 Eicosapentaenoic acid increases_expression of PPARG in kidney
11408 Docosahexaenoic acid increases_activity of PPARG in kidney
11409 Eicosapentaenoic acid increases_activity of PPARG in kidney
15698426 Diabetes mellitus, type II
Insulin resistance
1,668
12351 IKBKG affects_expression of PPARG in liver
18216263 Hepatocellular carcinoma
Diabetes mellitus, type II
Obesity
Insulin resistance
Fatty liver disease, nonalcoholic
1,674
12423 hyperglycemia decreases_expression of PPARG in adipose tissue
15536073 Diabetes mellitus, type II
Insulin resistance
1,888
14332 aging affects_activity of PPARG
14335 PPARG decreases_activity of inflammatory response by inhibiting the expression of inflammatory genes, such as cytokines, matrix metalloproteases
14336 PPARG affects_activity of Amyloid beta peptide in an Alzheimer's disease animal model
14337 NSAID affects_activity of PPARG in an Alzheimer's disease animal model
14355 PPARG decreases_expression of Cytokine
14403 Alzheimer disease NOT increases_quantity of PPARG
14404 PPARG affects_activity of Alzheimer disease
18313368 Alzheimer disease
1,987
15590 fat cell differentiation increases_expression of PPARG in adipose tissue
15602 Angiotensin II decreases_expression of PPARG in adipose tissue
15604 Irbesartan increases_expression of PPARG in adipose tissue
12031955 Diabetes mellitus, type II
Insulin resistance
1,997
15771 Telmisartan affects_activity of PPARG
20390403 Diabetes mellitus, type II
Obesity
Insulin resistance
Fatty liver disease, nonalcoholic
2,266
19353 SPP1 affects_expression of PPARG in liver
21562757 Diabetes mellitus, type II
Obesity
Insulin resistance
Fatty liver disease, nonalcoholic
2,278
19469 Alzheimer disease increases_expression of PPARG
19473 NSAID increases_activity of PPARG
19474 PPARG decreases_expression of Cytokine
19475 PPARG decreases_expression of NOS2
19481 PPARG is localized in microglia
19482 PPARG decreases_quantity of NO
19485 PPARG decreases_activity of PTGS2
19487 PPARG affects_quantity of Prostanoid
19543 PPARG increases_activity of beta-amyloid clearance
21345168 Alzheimer disease
2,341
36222 Troglitazone increases_activity of PPARG
9502777 Diabetes mellitus, type II
Insulin resistance
2,404
21413 PPARG increases_quantity of Insulin receptor after TNF treatment
21414 PPARG increases_quantity of IRS1 after TNF treatment
21415 PPARG NOT affects_phosphorylation of Insulin receptor after TNF treatment, at Tyr residues
21416 PPARG NOT affects_phosphorylation of IRS1 after TNF treatment, at Tyr residues
21417 PPARG NOT increases_quantity of 2-Deoxy-D-glucose after TNF treatment
11334412 Diabetes mellitus, type II
Insulin resistance
2,406
21435 Pioglitazone increases_activity of PPARG in peritoneal macrophages
19389833 Diabetes mellitus, type II
Insulin resistance
2,714
25332 PPARG2 rs1801282 NOT affects_expression of PPARG in colon, in pancreas, in liver
20703447 Diabetes mellitus, type II
Insulin resistance
-->